Inventor · disambiguated record
Bahija Jallal
Also filed as: JALLAL BAHIJA
9 granted patents·24 pending applications·216 citations·filing 1998–2016
88Inventor score
Top patents by PatentIndex Score
33 records- 0195US8337851B2Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancerAUKERMAN SHARON LEA·Filed 2006·Granted Dec 25, 2012·109 cites·62 claims
- 0289US8333970B2Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune diseaseAUKERMAN SHARON LEA·Filed 2006·Granted Dec 18, 2012·26 cites·51 claims
- 0388US6596772B1Phosphate mimics and methods of treatment using phosphatase inhibitorsSUGEN INC·Filed 2000·Granted Jul 22, 2003·53 cites·20 claims
- 0487US9193789B2Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseCOYLE ANTHONY·Filed 2012·Granted Nov 24, 2015·16 cites·20 claims
- 0563US7871786B2GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereofSUGEN INC·Filed 2008·Granted Jan 18, 2011·0 cites·6 claims
- 0662US2010143372A1Interferon alpha-induced pharmacodynamic markersMEDIMMUNE LLC·Filed 2007·Application pending·0 cites
- 0761US2015044222A1Interferon alpha-induced pharmacodynamic markers and uses thereofMEDIMMUNE LLC·Filed 2014·Application pending·0 cites
- 0860US2008279851A1Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 0958US7439329B2GEF-H1b: biomarkers, complexes assays and therapeutic uses thereofSUGEN INC·Filed 2003·Granted Oct 21, 2008·0 cites·2 claims
- 1057US2014302058A1Human anti il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseasesMEDIMMUNE LLC·Filed 2014·Application pending·0 cites
- 1156US2010261172A1Interferon alpha-induced pharmacodynamic markersMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 1256US2017121771A1Interferon alpha-induced pharmacodynamic markers and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 1354US7115710B2Diagnosis and treatment of PTP related disordersSUGEN INC·Filed 1998·Granted Oct 3, 2006·6 cites·5 claims
- 1454US2013230528A1Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signalingNOVARTIS AG·Filed 2012·Application pending·0 cites
- 1553US6844177B2Diagnosis and treatment of PTP04 related disordersSUGEN INC·Filed 2001·Granted Jan 18, 2005·0 cites·10 claims
- 1653US2015132313A1Interferon alpha-induced pharmacodynamic markersMEDIMMUNE LLC·Filed 2014·Application pending·0 cites
- 1752US2009215063A1Phosphospecific PAK antibodies and diagnostic kitsPFIZER·Filed 2009·Application pending·0 cites
- 1852US2017101468A1Human anti il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseasesMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 1951US2015147336A1Interferon alpha-induced pharmacodynamic markers and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 2050US6228641B1Diagnosis and treatment of PTP04 related disordersSUGEN INC·Filed 1998·Granted May 8, 2001·6 cites·15 claims
- 2150US2011159532A1GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOFSUGEN INC·Filed 2010·Application pending·0 cites
- 2249US2011243929A1Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 2348US2011262928A1Disease markers and uses thereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 2448US2004138255A1Phosphate mimics and methods of treatment using phosphatease inhibitorsSUGEN INC·Filed 2003·Application pending·0 cites
- 2547US2012034212A1Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory DiseasesBOWEN MICHAEL·Filed 2010·Application pending·0 cites
- 2646US2016024205A1Type I Interferon DiagnosticMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 2745US2012045775A1Phosphospecific pak antibodies and diagnostic kitsSMEAL TOD R·Filed 2011·Application pending·0 cites
- 2845US2011287022A1Interferon alpha-induced pharmacodynamic markersYAO YIHONG·Filed 2009·Application pending·0 cites
- 2945US2012251546A1Type 1 inteferon diagnosticHIGGS BRANDON·Filed 2010·Application pending·0 cites
- 3044US2005054017A1Phosphospecific PAK antibodies and diagnostic kitsSUGEN INC·Filed 2003·Application pending·0 cites
- 3144US2015191788A1Type 1 interferon diagnosticMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 3236US2008009610A1Diagnosis and treatment of PTP related disordersSUGEN INC·Filed 2007·Application pending·0 cites
- 3335US2006019305A1Diagnosis and treatment of PTP related disordersSUGEN INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bahija Jallal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →